🧬 **What If Gene Editing Could Happen Directly Inside the Human Body?**

For years, many gene and cell therapies followed a complex path:

**Remove cells → Edit them → Manufacture → Return them to the patient.**

Now, a new paradigm is emerging:

**Edit the cells directly inside the body.**

In vivo gene editing could potentially make genetic medicines faster, simpler, and more scalable — while opening the door to diseases and tissues that are difficult to treat with traditional ex vivo approaches.

Recent clinical progress is bringing this concept closer to reality, with in vivo CRISPR therapies showing promising results in human trials.

But the biggest challenges remain:

**Delivery. Specificity. Safety. Manufacturing.**

If scientists can solve these problems, gene editing may evolve from highly specialized treatments into a much broader therapeutic platform.

The question is no longer just:

**“Can we edit DNA?”**

It is:

**“Can we safely edit the right cells, in the right tissue, inside the right patient?”**

That could be the next major chapter of genetic medicine.

#GeneEditing #CRISPR #GeneTherapy #InVivoEditing #Biotechnology #GeneticMedicine #LifeSciences #Biotech